Ali Behbahani Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ali Behbahani.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ali Behbahani. Ali Behbahani is a 10% Owner in Marker Therapeutics, Inc. ($MRKR) and a Director in NEVRO CORP ($NVRO) and a Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and a 10% Owner in Regulus Therapeutics Inc. ($RGLS) and a 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and a Director in Adaptimmune Therapeutics PLC ($ADAP) and a 10% Owner in Metacrine, Inc. ($MTCR) and a Director in CRISPR Therapeutics AG ($CRSP) and a Director in Black Diamond Therapeutics, Inc. ($BDTX) and a Director in Oyster Point Pharma, Inc. ($OYST) and a 10% Owner in Akouos, Inc. ($AKUS) and a 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and a Director in Nkarta, Inc. ($NKTX).

Address: 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM 21093 MD

Companies in which Ali Behbahani is an Insider

Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 19,500,000 shares
Current Value: $88,335,000
Latest Transaction: Jul 01 2020
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 19,500,000
Shares Sold: 0
Share Difference: +19,500,000
Value Difference: -$25,000,650

Akouos, Inc.

Trading Symbol: AKUS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 513,758 shares
Latest Transaction: Jul 01 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 4,294,207
Shares Sold: 0
Share Difference: +4,294,207
Value Difference: -$9,999,995

Black Diamond Therapeutics, Inc.

Trading Symbol: BDTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 547 shares
Latest Transaction: Mar 22 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 3,449,304
Shares Sold: 0
Share Difference: +3,449,304
Value Difference: -$15,213,133

CRISPR Therapeutics AG

Trading Symbol: CRSP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 256 shares
Current Value: $4,032
Latest Transaction: Aug 14 2020
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 71
Shares Sold: 0
Share Difference: +71
Value Difference: $0

GENOCEA BIOSCIENCES, INC.

Trading Symbol: GNCA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 10,376,936 shares
Current Value: $46,799,981
Latest Transaction: Jul 28 2020
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 18,813,813
Shares Sold: 0
Share Difference: +18,813,813
Value Difference: -$31,778,948

Marker Therapeutics, Inc.

Trading Symbol: MRKR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 10,714,285 shares
Current Value: $47,678,568
Latest Transaction: Mar 18 2021
$MRKR Market Capitalization: $36.11M
$MRKR Previous Close: $4.45

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 5,714,285
Shares Sold: 0
Share Difference: +5,714,285
Value Difference: -$9,999,999

Metacrine, Inc.

Trading Symbol: MTCR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 1,958,333 shares
Latest Transaction: Sep 22 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 3,060,527
Shares Sold: 0
Share Difference: +3,060,527
Value Difference: -$9,999,990

Mirum Pharmaceuticals, Inc.

Trading Symbol: MIRM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 3,736,243 shares
Latest Transaction: Jul 24 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 16,744,972
Shares Sold: 0
Share Difference: +16,744,972
Value Difference: -$27,000,000

NEVRO CORP

Trading Symbol: NVRO
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Ali Behbahani: Director
Holdings: 5,390 shares
Current Value: $503,049
Latest Transaction: May 23 2018
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 0x
Shares Bought: 9,150
Shares Sold: 0
Share Difference: +9,150
Value Difference: $0

Nkarta, Inc.

Trading Symbol: NKTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: Director
Holdings: 0 shares
Latest Transaction: Jul 13 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Oyster Point Pharma, Inc.

Trading Symbol: OYST
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 6,600 shares
Latest Transaction: Jun 10 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 13,200
Shares Sold: 0
Share Difference: +13,200
Value Difference: $0

Regulus Therapeutics Inc.

Trading Symbol: RGLS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 6,451,056 shares
Current Value: $9,031,478
Latest Transaction: Dec 07 2020
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 5,535,306
Shares Sold: 0
Share Difference: +5,535,306
Value Difference: -$3,963,571

Trevi Therapeutics, Inc.

Trading Symbol: TRVI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali Behbahani: 10% Owner
Holdings: 5,938,562 shares
Latest Transaction: Apr 13 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 1x
Shares Bought: 5,938,562
Shares Sold: 564
Share Difference: +5,937,998
Value Difference: -$25,000,000

Latest Insider Trading Transactions of Ali Behbahani

Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 22 2021BDTXBlack Diamond Ther ...Behbahani AliDirectorGrantA24.0154713,1335470 to 547
Mar 18 2021MRKRMarker Therapeutic ...Behbahani Ali10% OwnerBuyP1.755,714,2859,999,99910,714,2855 M to 10.7 M (+114.29 %)
Dec 07 2020RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerOption ExerciseP0.00258,7070258,707
Dec 07 2020RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerOption ExerciseP0.755,239,2543,910,5795,239,254
Dec 07 2020RGLSRegulus Therapeuti ...Behbahani Ali10% OwnerBuyP0.624,398,6022,735,9306,451,0562.1 M to 6.5 M (+214.31 %)
Sep 22 2020MTCRMetacrine, Inc.Behbahani Ali10% OwnerOption ExerciseC0.00332,96400
Sep 22 2020MTCRMetacrine, Inc.Behbahani Ali10% OwnerOption ExerciseC0.001,958,33300

View all Ali Behbahani insider transactions.